scholarly article | Q13442814 |
P2093 | author name string | M. A. Kaliner | |
M. V. White | |||
R. J. Hohman | |||
H. C. Kaulbach | |||
B. L. Mosimann | |||
M. S. Goldrich | |||
P433 | issue | 1 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 95-104 | |
P577 | publication date | 1993-07-01 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients | |
P478 | volume | 92 |
Q37015446 | A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. |
Q39671915 | Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis |
Q104064365 | Allergic rhinitis |
Q36795267 | Bitter and sweet taste receptors in the respiratory epithelium in health and disease |
Q71289849 | Calcitonin gene-related peptide in vitro stimulation of ciliary beat in human upper respiratory cilia |
Q49064177 | Capsaicin-induced vasodilatation in human nasal vasculature is mediated by modulation of cyclooxygenase-2 activity and abrogated by sulprostone. |
Q38196334 | Cytokine profiles in allergic rhinitis |
Q73147021 | Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps |
Q71439397 | Determination of substance P in human nasal lavage fluid |
Q47878498 | Distribution and quantity of neuroendocrine markers in allergic rhinitis |
Q35110517 | Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons |
Q48758082 | Effect of intravenous calcitonin gene-related peptide antagonist on the laryngeal chemoreflex in piglets. |
Q32019400 | Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis |
Q58083612 | Expression of Substance P (NK1) Receptor mRNA in Human Nose |
Q80725498 | Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method |
Q35552822 | H1-receptors: localization and role in airway physiology and in immune functions |
Q72192519 | HLA immunogenetics and specific IgE responses to allergens |
Q33855065 | Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease |
Q30498710 | Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans |
Q52594640 | Interactions of the immune and sensory nervous systems in atopy. |
Q81886305 | Intranasal trigeminal sensitivity in subjects with allergic rhinitis |
Q38907362 | Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography |
Q71843769 | Lack of association between HLA‐DQ and ‐DR genotypes and asthma in southern Chinese patients |
Q36836039 | Measurement of bioactive neuropeptides using a chromatographic immunosensor cartridge |
Q77759930 | Mechanisms of allergic rhinitis |
Q44163611 | Nasal and skin histamine responses in allergic rhinitis |
Q54079157 | Nasal reactivity to capsaicin in patients with seasonal allergic rhinitis during and after the pollen season. |
Q36793272 | Nasonasal reflexes, the nasal cycle, and sneeze |
Q44355180 | Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis |
Q47800446 | Neuro-immune interactions in allergic diseases: novel targets for therapeutics |
Q47921833 | Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases |
Q42572503 | Neurogenic inflammation in human airways: is it important? |
Q34561650 | Neurogenic mechanisms in rhinosinusitis |
Q82423208 | Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP) |
Q89581125 | Neuropeptide regulation of secretion and inflammation in human airway gland serous cells |
Q42138353 | Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models |
Q33750651 | Pathophysiology of the inflammatory response |
Q42708177 | Potentiation by viral respiratory infection of ovalbumin‐induced guinea‐pig tracheal hyperresponsiveness: role for tachykinins |
Q58596146 | Role of Taste Receptors as Sentinels of Innate Immunity in the Upper Airway |
Q33899646 | Role of tachykinins in asthma |
Q37215899 | Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid |
Q40461697 | Taste Receptors: Regulators of Sinonasal Innate Immunity. |
Q38260860 | Taste receptors in innate immunity |
Q34493847 | Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. |
Q34366396 | The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. |
Q36795289 | The Role of Bitter and Sweet Taste Receptors in Upper Airway Immunity. |
Q64911505 | The role of bitter and sweet taste receptors in upper airway innate immunity: Recent advances and future directions. |
Q41757345 | The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles |
Q37346160 | Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration |
Q37360187 | Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells |
Q34561632 | Viral rhinitis |
Q80196993 | [Auricular chondritis. Experimental model in rats] |
Search more.